Pediatric Type 1 Diabetes Onset Data with Vitamin D Levels, 2023-2025

A retrospective chart review of 99 children under 18 years old with new-onset Type 1 Diabetes Mellitus diagnosed at a Northwell Health practice between June 2023 and February 2025. The dataset, authored by Sofya Ilmer, includes 25-hydroxyvitamin D levels measured at diagnosis, demographic data, and clinical markers of diabetic ketoacidosis severity and beta-cell function.

Use Cases

• Analyze the association between 25-hydroxyvitamin D levels and diabetic ketoacidosis severity based on pH, bicarbonate, and beta-hydroxybutyrate measures.
• Model the relationship between vitamin D status and the odds of presenting with diabetic ketoacidosis at diagnosis.
• Investigate potential links between demographic factors (race, ethnicity, insurance status) and initial diabetes presentation.
• Explore correlations between biochemical markers of beta-cell function (insulin, C-peptide) and other clinical variables.

Strengths

• Includes data from 99 pediatric patients with confirmed new-onset Type 1 Diabetes.
• Contains specific clinical measures: 25-hydroxyvitamin D levels, hemoglobin A1C, and DKA severity markers (pH, bicarbonate, beta-hydroxybutyrate).
• Statistical results, including correlation coefficients and odds ratios, are provided in the description for context.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is from a single pediatric endocrinology practice, which may limit generalizability.

Provenance

Source

Retrospective chart review from a pediatric endocrinology practice at Northwell Health.

Collection Method

Data extracted from electronic health records of patients diagnosed with positive diabetes-specific autoantibodies.

Time Range

June 2023 to February 2025

Freshness

Last updated 2026-04-23 04:16:31; freshness should be verified.

Geography

null